ğŸ§  Drug Prediction for Patients using Machine Learning
This repository contains a machine learning model developed to predict the most appropriate drug treatment for patients based on their clinical and biochemical profiles. The system integrates data-driven healthcare and artificial intelligence to support decision-making in personalized medicine.

ğŸ“Š Project Overview
The model utilizes 2,900 anonymized patient records, each containing 18 critical biochemical parameters such as:

Glucose
Urea
Creatinine
ALT (Alanine Transaminase)
AST (Aspartate Transaminase)
CRP (C-Reactive Protein)
Hemoglobin
TSH
WBC (White Blood Cell count) and others relevant to disease diagnosis.

These parameters are used to predict a disease class and provide drug recommendations based on clinical pharmacological guidelines.

ğŸ¥ Study Design
Type of Study: Retrospective
Data Source: Patient records from AtatÃ¼rk University Research Hospital
Study Period: January 1, 2020 â€“ June 1, 2024
Ethical Approval: Approved by the Ethics Committee of AtatÃ¼rk University Research Hospital
All necessary ethical permissions were obtained prior to data analysis.

ğŸ‘©â€ğŸ”¬ This study was conducted in collaboration with my last-term pharmacy students, Cansu Ã‡elik and Berivan Aslan.

ğŸ§¬ Disease Classification
Each patient record is labeled with one of the following 9 disease classes:

Class	Disease
0	Renal Failure
1	Anemia
2	Diabetes
3	Hypercholesterolemia
4	Hyperthyroidism
5	Hypothyroidism
6	Heart Attack
7	Pneumonia
8	Healthy

ğŸ¤– Technical Implementation
Programming Language: Python
Framework: TensorFlow
Model: Deep Neural Network (DNNClassifier)
Purpose: Multiclass classification of diseases and drug recommendation mapping
The DNNClassifier model was trained using normalized biochemical parameters as input features. It outputs a predicted disease class label, which is then used to generate rule-based drug recommendations.

ğŸ’Š Drug Recommendation System
After the disease is predicted, the model provides personalized drug suggestions based on standard clinical treatment protocols. Recommendations are tailored to the patientâ€™s biochemical state and associated disease class:

ğŸ”¹ Class 0 â€“ Renal Failure
Drugs: ACE inhibitors (e.g., Enalapril), ARBs, Phosphate binders, Erythropoiesis-stimulating agents
Based on: Elevated creatinine, urea, electrolyte imbalance, and low hemoglobin
ğŸ”¹ Class 1 â€“ Anemia
Drugs: Ferrous sulfate (oral/IV), Vitamin B12, Erythropoietin
Based on: Low hemoglobin, hematocrit, and iron indices
ğŸ”¹ Class 2 â€“ Diabetes
Drugs: Metformin, Insulin, DPP-4 inhibitors, SGLT2 inhibitors
Based on: Elevated glucose, HbA1c (if available), and renal function
ğŸ”¹ Class 3 â€“ Hypercholesterolemia
Drugs: Statins (e.g., Atorvastatin), Ezetimibe, PCSK9 inhibitors
Based on: High total cholesterol, LDL levels
ğŸ”¹ Class 4 â€“ Hyperthyroidism
Drugs: Methimazole, Propylthiouracil, Beta-blockers (e.g., Propranolol)
Based on: Suppressed TSH, elevated free T4 or T3
ğŸ”¹ Class 5 â€“ Hypothyroidism
Drugs: Levothyroxine
Based on: Elevated TSH, low free T4
ğŸ”¹ Class 6 â€“ Heart Attack (Myocardial Infarction)
Drugs: Aspirin, Clopidogrel, Beta-blockers, ACE inhibitors, Statins
Based on: Elevated troponin, ECG data, abnormal CRP, and blood pressure values
ğŸ”¹ Class 7 â€“ Pneumonia
Drugs: Empirical antibiotics â€“ Amoxicillin-clavulanate, Azithromycin, or Ceftriaxone
Based on: High CRP, WBC count, fever, and clinical signs (if available)
ğŸ”¹ Class 8 â€“ Healthy
Recommendation: No drug suggested; patient considered clinically normal. Routine monitoring advised.
## ğŸ’¡ Authors
ğŸ”¬ Harun Un, PhD â€“ Clinical Biochemist & Data Scientist
ğŸ”¬ Cansu Celik, BSc â€“ Pharmacist 
ğŸ”¬ Berivan Aslan, BSc â€“ Pharmacist
